Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
Turning Point Therapeutics, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Novartis
Revolution Medicines, Inc.
Pfizer
Metanoic Health Ltd.
Hoffmann-La Roche
Origin Sciences
Magentiq Eye LTD
Kyowa Kirin Co., Ltd.
Catalysis SL
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Magentiq Eye LTD
Novartis
AbbVie
Isofol Medical AB
Isofol Medical AB
Isofol Medical AB
LEO Pharma
Exact Sciences Corporation
EndoAid
Merck KGaA, Darmstadt, Germany
Metabiomics Corp
Exact Sciences Corporation
Exact Sciences Corporation
Shenzhen Hornetcorn Bio-technology Company, LTD
Exact Sciences Corporation
Exact Sciences Corporation
Exact Sciences Corporation
Merck Sharp & Dohme LLC